46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03285191 (ClinicalTrials.gov) | July 3, 2017 | 29/6/2017 | Subject Insights to Understand Rheumatoid Arthritis (RA) | Patient Interviews to Better Understand Disease Experience and Unmet Treatment Needs in Rheumatoid Arthritis | Arthritis, Rheumatoid | Other: Numerical rating scale;Other: Real-time data capture app | GlaxoSmithKline | NULL | Completed | 18 Years | N/A | All | 30 | United Kingdom | |
| 2 | NCT00378261 (ClinicalTrials.gov) | January 2004 | 15/9/2006 | APART Advanced Profiling of Anti-Rheumatic Therapies | A Multicenter, Randomized, Open Study to Evaluate the Impact of an Electronic Data Capture System on the Care of Patients With Rheumatoid Arthritis | Arthritis, Rheumatoid | Procedure: Use of an Electronic Data Capture System by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in RA subjects. | Centocor Ortho Biotech Services, L.L.C. | NULL | Completed | 18 Years | N/A | Both | 1079 | Phase 4 | NULL |